BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210907
DTEND;VALUE=DATE:20210910
DTSTAMP:20260515T212834
CREATED:20210429T150915Z
LAST-MODIFIED:20210429T150915Z
UID:29950-1630972800-1631231999@www.pharmajournalist.com
SUMMARY:Next Generation Cancer Vaccine Development Summit 2021
DESCRIPTION:Cancer remains one of the most challenging diseases we face today. Standard treatment protocols (chemotherapy\, radiotherapy\, and surgical intervention) are often hampered by toxic side effects and concomitant malignancies. Vaccines offer a promising alternative to unleash the most powerful force against cancer: our own immune system! \n \nAt the inaugural Next Generation Cancer Vaccine Development Summit (September 7-9\, Digital Event) join the likes of Gritstone Oncology\, BioNTech\, Janssen\, (and much more!) as we come together to delve deep into understanding the tumor microenvironment\, optimising antigen selection\, and analyzing a multitude of novel platforms and combination therapies to finally bring safe and effective cancer vaccines to market. \nLearn more here: https://ter.li/m1zx7a
URL:https://www.pharmajournalist.com/event/next-generation-cancer-vaccine-development-summit-2021/
LOCATION:100% Digital Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210907
DTEND;VALUE=DATE:20210910
DTSTAMP:20260515T212834
CREATED:20210517T084245Z
LAST-MODIFIED:20210517T084245Z
UID:30194-1630972800-1631231999@www.pharmajournalist.com
SUMMARY:2nd Operationalize: Decentralized Clinical Trials Summit
DESCRIPTION:By bringing together the world’s leading Decentralized Clinical Trials thinkers\, the 2nd Operationalize: Decentralized Clinical Trials Summit will clarify the complex issues through end-to-end remote\, decentralized\, and siteless clinical trial program operationalization. Through open discussion\, sharing best-practice case studies\, and removing the hypothetical: this meeting is your best chance to solve your challenges based on the wealth of experience collected in the last year of trial adaption. \n \nWhether it’s trial set-up\, technological integration\, negotiating with stakeholders\, hybridization\, patient communication\, and choice provision: ensure you aren’t repeating past mistakes by hearing global leaders recall their experience with a shared goal of providing you with pragmatic solutions to solve these complex hurdles. \nFeaturing real-life case studies and experiences as well as interactive panel discussions and virtual roundtables from the likes of PRA Health Sciences\, Boehringer Ingleheim\, Janssen\, Decentralized Trials & Research Alliance\, and the Digital Medicine Society\, this is your opportunity to find the answers to your most burning decentralized clinical trials challenges. \nJoin us to lead the industry by offering patients more flexibility through decentralized trials. \nTo know more about 2nd Operationalize: Decentralized Clinical Trials Summit please click here.
URL:https://www.pharmajournalist.com/event/2nd-operationalize-decentralized-clinical-trials-summit/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210907
DTEND;VALUE=DATE:20210908
DTSTAMP:20260515T212834
CREATED:20210802T111449Z
LAST-MODIFIED:20210802T111449Z
UID:31182-1630972800-1631059199@www.pharmajournalist.com
SUMMARY:Multiscale and multi-modal insights into drug formulation
DESCRIPTION:SMi Group are delighted to introduce a free exclusive webinar taking place on 7th September 2021 at 3pm BST\, hosted by Zeiss. \nSynopsis / Webinar Overview: \nThe majority of pharmaceutical powders require a size <500 μm for ease of manufacture and biopharmaceutical performance. Powder behaviour of particles in this size-range spans cohesive to aeratable powders. Powder performance is dependent on the powder bulk density and micromeritic properties of individual particles\, but also crucially the structuring of particles within the powder bed. Micromeritic assessment is also routinely performed using image analysis or particle sizing techniques such as laser diffraction analysis. However\, there is a clear need for techniques that provide non-destructive granular information of pharmaceutical powder structures. \nFormulation equivalence between different batches of products or between comparator innovator and generic products has emerged as a hot topic of consideration in regulatory science. Microstructural equivalence (Q3) for powder products is complex\, and particularly in the case of Dry Powder Inhalation (DPI) formulations. It is in the characterization of the bulk powder that microstructural assessment is a particular challenge. Current methods for measuring critical material attributes such as the particle size and shape suffer from low resolution\, image in 2D or make shape assumptions. \nIn this webinar\, we will present some new approaches using X ray Microscopy (XRM) from nano- to micro-scale that can be utilized for characterizing inhalation powder blends non-destructively to obtain fully 3D information on particle size and shape\, its distributions\, and powder bed packing. Novel methodologies developed to identify individual chemical phases within blends\, their crystal orientations and interactions in 3D will also be presented. The results show the promise for XRM as a valuable powder characterisation technique that develops our fundamental understanding of powder microstructure\, and microstructural descriptors for the United States Food and Drug Administration Q3 microstructural assessments. \nRegister your free place: http://www.drug-formulation-zeiss-webinar.com/pjwl \nWho will be speaking? \nDr Hrishikesh Bale – Marketing Solutions Manager\, Engineering Materials\nCarl Zeiss – Research Microscopy Solutions \nKey Takeaways \nIn this webinar you will learn: \n\nAbout the importance of pharmaceutical powder microstructure and the current landscape of the methods for microstructural characterization\nHow X-ray Microscopy (XRM) can provide information on key microstructrual metrics\, as well as the interaction between formulation components\nHow the unique microstructural insight provided by XRM can help understand powder performance\nAbout a range of applications of XRM to pharmaceutical powders\, including powder beds and complex inhalation formulations\n\nRegister your free place: http://www.drug-formulation-zeiss-webinar.com/pjwl \nWho is this webinar aimed at? \nThis interactive webinar is designed for all users\, from both academic and industrial sectors\, who are interested in powder characterisation. The webinar is suitable for both a technical and non-technical audience and will provide insight into applications of XRM as a microstructural characterisation technique. \nAdditional Contact Info: \nT: +44 (0)20 7827 6088 \nE: hsidhu@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/multiscale-and-multi-modal-insights-into-drug-formulation/
LOCATION:Webinar | 15pm BST
ORGANIZER;CN="SMi Events":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
END:VCALENDAR